GNMSF Institutional Ownership
Genmab A/S
1W: +13.0%
1M: +23.7%
3M: +51.8%
YTD: +39.8%
1Y: +47.7%
3Y: +46.5%
5Y: -2.2%
$439.05
-8.50 (-1.90%)
Weekly Expected Move ±10.1%
$357
$402
$448
$493
$538
Credit Risk of going bust: lower than 69% of companies Debt: 16.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $6.37 (down 99%), Genmab A/S would be worth roughly what it owes.
Total debt $5.27B against a stock market value of $27.47B.
Distance to default 7.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $5.27B against a stock market value of $27.47B.
Distance to default 7.47 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $2.71B (short-term plus half of long-term), stock volatility 35.1%; Altman Z'' 3.61. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
No institutional holdings data available for GNMSF
Institutional holdings are sourced from SEC 13F filings and may not be available for all securities.